amphotericin B liposomal

Known as: liposomal amphotericin B [Chemical/Ingredient], Amphotericin B-Lipid Complex, Lipid Complex, Amphotericin B 
A liposome-encapsulated formulation of the polyene antifungal antibiotic amphotericin B produced by the bacterium Streptomyces nodosus with… (More)

Topic mentions per year

Topic mentions per year

1955-2018
05010015019552017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
BACKGROUND Some 50% of patients with visceral leishmaniasis (kala-azar) worldwide live in the Indian state of Bihar. Liposomal… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Invasive candidosis is increasingly prevalent in seriously ill patients. Our aim was to compare micafungin with… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Treatment of invasive mold infection in immunocompromised patients remains challenging. Voriconazole has been shown to… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Caryn Bern, Jill Adler-Moore, Juan Berenguer, Marleen Boelaert, Margriet den Boer, Robert N. Davidson, Concepcion Figueras, Luigi… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Patients with persistent fever and neutropenia often receive empirical therapy with conventional or liposomal… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Patients with neutropenia and persistent fever are often treated empirically with amphotericin B or liposomal… (More)
  • table 3
  • table 4
  • figure 1
  • table 5
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Biofilms, likely the predominant mode of device-related microbial infection, exhibit resistance to antimicrobial agents. Evidence… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
In this double-blind study to compare safety of 2 lipid formulations of amphotericin B, neutropenic patients with unresolved… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND In patients with persistent fever and neutropenia, amphotericin B is administered empirically for the early treatment… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
The safety and antifungal efficacy of amphotericin B lipid complex (ABLC) were evaluated in 556 cases of invasive fungal… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 3
Is this relevant?